Navigation Links
FDA debates status of decongestant drugs

An advisory committee for the Food and Drug Administration agreed that an ingredient commonly used in over-the-counter decongestants is unsafe, and it plans to recommend further review by the FDA.

The FDA Non-Prescription Drugs Advisory Committee met to discuss a new five-year study by Yale University researchers that found phenyl-propanolamine (PPA), an active ingredient in non-prescription drugs, can increase the risk of stroke in some users. PPA helps constrict blood vessels, thus relieving nasal congestion, and has been shown to aid in weight loss.// The compound is in hundreds of over-the-counter cold, cough and allergy medicines and appetite suppressants.

And while products containing such ingredients are required to list such warnings on their labels, the warnings often go unnoticed or ignored by many who assume over-the-counter drugs are safe for one and all. One big reason such warnings may be ignored is because nearly half of the estimated 50 million people in the United States with high blood pressure don't even realize they have a problem.

The problem is that the active ingredients in many decongestants can't target the blood vessels in the nose. Instead, they constrict blood vessels throughout your body, and raise your blood pressure. If you already have high blood pressure, that can increase your risk for stroke or heart attack.

Furthermore, the decongestants can work against anti-hypertensive drugs that patients might take for their high blood pressure. There are over-the-counter cold and flu products that claim to be safe for people with high blood pressure, but they're unlikely to help those looking for a decongestant.
'"/>




Page: 1

Related medicine news :

1. Patient’s perception of health status helps in better recover
2. Jharkhand Gives Health industry status
3. Gay and HIV + men have no qualms revealing HIV status
4. Specialist status for breast doctors may be revoked
5. The connection between socioeconomic status and risk of stroke
6. Cancer drugs in development nearly doubled since 1995
7. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
8. African HIV strains more resistant to anti HIV drugs
9. Right drugs drastically cut stroke risk
10. Relating heart protection and antihypertensive drugs
11. Enzyme may be target for obesity drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... Kenneth ... International AIDS Society (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board ... is the founding Medical Research Director of Fenway Health and Co-Chair of ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... HOUSTON – ... new website and a host of new options for today’s modern senior. Brazos ... maintain the active, independent lifestyle they love while offering them the services to support ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... content solutions for the enterprise, is proud to announce Touchpoints integrations. ... ticketing systems, company websites, and more to provide a seamless customer experience. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a ... Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without ...
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... 2017  In response to the opioid epidemic in ... is working with Pfizer to make up to 1 ... to community health centers, free and charitable clinics, public ... "Pfizer has a long-standing commitment to improving health ... safety through educational activities," said Caroline Roan , ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: